Carla M. Davis, MD
- Allergy and Immunology
Chief, Section of Immunology, Allergy and Retrovirology
Director, Food Allergy Program
Janie and Sandra Queen Endowed Chair in Immunology and HIV/AIDS
Professor of Pediatrics, Baylor College of Medicine
Phone:
832-824-1319
Fax:
832-825-1260
Languages: English
Office locations:
Texas Medical Center
6701 Fannin Street
Houston, TX 77030
Get to know Carla M. Davis, MD
Dr. Davis is the Chief of the Immunology, Allergy, and Retrovirology Division of the Department of Pediatrics at Baylor College of Medicine. She received her medical degree from Duke University and completed her residency program in pediatrics and her allergy and immunology fellowship at Baylor College of Medicine. After spending time in private practice, she joined the Baylor faculty and was appointed as a Professor in the Department of Pediatrics, Immunology, Allergy, and Retrovirology Division in 2020. Dr. Davis is focused on improving the quality of life for infants, children, and adolescents with food allergies. She is dedicated to providing patients and their families with unparalleled, personalized, family-centered care. She is ultimately dedicated to finding causes and cures for food allergies and food allergy-related diseases.
Dr. Davis has published in the area of food allergy and immunodeficiency with a focus in the underlying immune mechanism of disease. In 2009, her interest in the diagnosis and treatment of food allergic disease and eosinophilic esophagitis (EoE) increased and she established a clinic dedicated to the treatment of eosinophilic gastrointestinal disorders (EGID) at Texas Children's Hospital in collaboration with the Section of Gastroenterology, Hepatology, and Nutrition. This multi-disciplinary clinic with an allergist, gastroenterologist, and dietician currently extensively evaluates patients for food allergies and is equipped with a dedicated dietitian to offer nutrition support.
Dr. Davis is the Director of the Texas Children's Hospital Food Allergy Program, which is involved in several NIH-funded clinical trials. She is currently recognized as an expert in the field and has served as a member of the Board of Directors of the American Academy of Allergy, Asthma, and Immunology.
Clinical Interests
Food allergies, eosinophilic gastrointestinal disorders, asthma, allergic rhinitis, atopic dermatitis, anaphylaxis and hives, recurrent infections
Education
School | Education | Degree | Year |
---|---|---|---|
Baylor College of Medicine | Research Fellowship | Research | 2005 |
Baylor College of Medicine | Fellowship | Allergy and Immunology | 2001 |
Baylor College of Medicine | Residency | Pediatrics | 2000 |
Baylor College of Medicine | Internship | Pediatrics | 1998 |
Duke University Medical Center | Medical School | Doctor of Medicine | 1997 |
Howard University | Bachelors | Bachelor of Science in Chemical Engineering | 1992 |
Organizations
Organization Name | Role |
---|---|
American Academy of Pediatrics | Member of the Section of Allergy and Immunology |
American Pediatric Society | Board of Directors |
American Academy of Allergy, Asthma & Immunology | Fellow |
American College of Allergy, Asthma & Immunology | Fellow |
Association of Clinical Scientists | Fellow |
Texas Allergy, Asthma and Immunology Society | Past-President (2022-2024) |
Texas Department of State Health Services (DSHS) | Chair, Ad Hoc Committee for Development of Guidelines for Policies for Care of Certain Students at Risk for Anaphylaxis; State Bill 66 Committee (2017-2019, Member (2020-Present) |
Honors and awards
- 2021
-
Beyond Duke Service and Leadership Award
- 2019
-
Honorary AAAAI William T. Shearer and Lynn Des Prez Lectureship Award
- 2019
-
American Pediatric Society
- 2019
-
Norton Rose Fulbright L. L. P. Faculty Excellence Award for Educational Research, Baylor College of Medicine
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Research interests
Eosinophilic gastrointestinal disorders, health disparities
Davis CM, Anagnostou A, Devaraj S, Vita DT, Rivera F, Pitts K, Hearrell M, Minard C, Guffey D, Gupta M, Watkin L, Orange JS, Anvari S. Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD study). J Allergy Clin Immunol Pract. 2021 Dec 7:S2213-2198(21)01363-5. doi: 10.1016/j.jaip.2021.10.074. Epub ahead of print. PMID: 34890827.
Davis CM, Morris E, Nanda A, Louisias M, Apter A, Foggs M, Walker-McGill CL, Wang J, Perry TT. Allergic Conditions in the Underserved, A Work Group Report of the AAAAI Committee on the Underserved. Journal of Allergy and Clinical Immunology. J Allergy Clin Immunol. 2021;147(5):1579-1593.
Nguyen DI, Sindher SB, Chinthrajah RS, Nadeau K, Davis CM. Shrimp-allergic patients in a multi-food oral immunotherapy trial. Pediatr Allergy Immunol. 2021 Oct 16. doi: 10.1111/pai.13679. Epub ahead of print. PMID: 34655480.
Davis CM, Lange L, Beyer K, Fleischer DM, Ford L, Sussman G, Oriel RC, Pongracic JA, Shreffler W, Bee KJ, Campbell DE, Green TD, Lambert R, Peillon A, Bégin P. Efficacy and Safety of Peanut Epicutaneous Immunotherapy in Patients With Atopic Comorbidities. JACI Global. 2022 Sept 21. doi: https://doi.org/10.1016/j.jacig.2022.07.009
Anvari S, Brunner S, Tuano KS, Su BB, Karnaneedi S, Lopata AL, Davis CM. Similar IgE binding patterns in Gulf of Mexico and Southeast Asian shrimp species in US shrimp allergic patients. Allergy. 2022 Sep;77(9):2825-2829. doi: 10.1111/all.15363. Epub 2022 Jun 2. PMID: 35524542.
Anvari S, Watkin LB, Minard CG, Schuster K, Hassan O, Anagnostou A, Orange JS, Corry DB, Davis CM. Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy. PLoS One. 2022 May 26;17(5):e0264674. PMID: 35617270
Davis CM, Flohr C, Gupta MR, Koplin JJ. Managing Atopic Dermatitis in Patients With Skin of Color. J Allergy Clin Immunol Pract. 2023 May;11(5):1376-1383. doi: 10.1016/j.jaip.2023.03.041. Epub 2023 Mar 29. PMID: 37001639.